Trials / Completed
CompletedNCT03568175
A Study of JR-141 in Patients With Mucopolysaccharidosis II
A Phase II/III Study of JR-141 in Patients With Mucopolysaccharidosis II
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- JCR Pharmaceuticals Co., Ltd. · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A Phase II/ III multicenter, open-label, single-group, designed to evaluate the efficacy and safety of study drug for the treatment of the MPS II.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JR-141 | IV infusion, 2.0 mg/kg/week |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2020-02-20
- Completion
- 2020-02-20
- First posted
- 2018-06-26
- Last updated
- 2022-11-14
Locations
19 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03568175. Inclusion in this directory is not an endorsement.